NovoCure (NVCR) Change in Account Payables (2014 - 2019)

NovoCure's Change in Account Payables history runs 6 years deep, the most recent figure standing at $126000.0 for Q2 2019.

• In Q2 2019, Change in Account Payables fell 87.6% year-over-year to $126000.0; the TTM figure through Jun 2019 stood at $9.6 million (up 32.44% YoY), while the FY2018 annual figure was $9.5 million, up 926.35% from the prior year.
• Change in Account Payables came in at $126000.0 for Q2 2019 at NovoCure, down from $3.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.7 million in Q4 2018 to a low of -$6.8 million in Q3 2016.
• A 5-year average of $1.1 million and a median of $1.7 million in 2015 frame the typical range for Change in Account Payables.
• On a YoY basis, Change in Account Payables climbed as much as 371.28% in 2016 and fell as far as 547.42% in 2016.
• NovoCure's Change in Account Payables stood at $2.4 million in 2015, then soared by 78.6% to $4.2 million in 2016, then declined by 27.45% to $3.1 million in 2017, then surged by 117.27% to $6.7 million in 2018, then plunged by 98.11% to $126000.0 in 2019.
• According to Business Quant data, Change in Account Payables over the past three periods registered $126000.0, $3.2 million, and $6.7 million for Q2 2019, Q1 2019, and Q4 2018 respectively.

Peer Comparison